New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.
These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing memory loss in preclinical models. These findings were presented today at the American Association for the Advancement of Science (AAAS) Annual Meeting in Washington DC.
“Currently there are no medications to treat cognitive symptoms such as memory loss that occur in depression, other mental illnesses and aging,” says Dr. Etienne Sibille, Deputy Director of the Campbell Family Mental Health Research Institute at CAMH and lead scientist on the study.
What’s unique and promising about these findings, in the face of many failures in drug development for mental illness, is that the compounds are highly targeted to activate the impaired brain receptors that are causing memory loss, he says.
It took a series of studies – the most recent appearing in January 2019 in Molecular Neuropsychiatry – to reach this stage. First, Dr. Sibille and his team identified the specific impairments to brain cell receptors in the GABA neurotransmitter system. Then they showed that these impairments likely caused mood and memory symptoms in depression and in aging.
The new small molecules were invented to bind to and activate this receptor target. The idea was that they would exert a therapeutic effect by “fixing” the impairment, resulting in an improvement in symptoms. The molecules are chemical tweaks of benzodiazepines, a class of anti-anxiety and sedative medications that also activate the GABA system, but are not highly targeted.
A single dose of these new molecules was administered in preclinical models of stress-induced memory loss. Thirty minutes later, memory performance returned to normal levels, an experiment that was reproduced more than 15 times. In another experiment involving preclinical models of aging, memory declines were rapidly reversed and performance increased to 80 per cent after administration, essentially reaching levels seen in youth or earlier stages of adulthood. This improvement lasted over two months with daily treatment.
“The aged cells regrew to appear the same as young brain cells, showing that our novel molecules can modify the brain in addition to improving symptoms,” says Dr. Sibille. He expects to start testing the molecules in clinical research in two years. “We’ve shown that our molecules enter the brain, are safe, activate the target cells and reverse the cognitive deficit of memory loss.”
If successful, the potential applications are broad. Not only is there a lack of treatment for cognitive deficits in mental illness, but the brain improvements suggest the molecules could help to prevent the memory loss at the beginning of Alzheimer’s disease, potentially delaying its onset.
The Latest on: Memory loss and depression
[google_news title=”” keyword=”memory loss and depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Memory loss and depression
- Clear Probiotics Brain & Mood Review - Is Clear Brain And Mood Supplement Right For You?on November 18, 2022 at 11:13 am
Moreover, this medication was formulated by scientists who figured out the cause of illnesses such as lack of focus, pimples, brain fog, memory loss, gas ... and relieving depression and anxiety. It ...
- Today's Marijuana is "More Potent" and May be More Dangerous, Says New Researchon November 18, 2022 at 4:15 am
Experts explain what to know about high potency cannabis and damaging side effects that could happen as a result of taking it.
- Patients suffering with hard-to-treat depression may get relief from noninvasive magnetic brain stimulationon November 16, 2022 at 5:36 am
a procedure used for patients with severe depression or catatonia. With electroshock therapy, the anesthetized patient receives a direct electrical current, which causes a seizure. Typically, people ...
- Antidepressants, part 2: Your experiences and follow-up questionson November 15, 2022 at 11:00 am
We asked you to tell us about your experiences with depression and antidepressants, and we received so many diverse and honest accounts.
- New 'brain zapper' may help to treat depressionon November 9, 2022 at 5:00 pm
MINUTE daily burst of a mild electromagnetic current can ease difficult-to-treat depression, according to a new study.
- Dementia Has "Hidden" Symptoms and Here's How to Tell You Have Themon November 8, 2022 at 4:30 am
Hearing loss often results in a person not hearing conversations, or misunderstanding them. At a minimum, hearing loss contributes to cognitive impairment in dementia. It's unclear whether hearing ...
- Study Finds Not Treating Depression May Increase The Risk Of Dementiaon October 28, 2022 at 11:38 pm
According to the data of of the World Health Organization, dementia is the seventh leading cause of death worldwide. About 55 million people live with the severity of ths disorder which affects ...
- 8 causes of short-term memory loss and how to combat iton October 19, 2022 at 8:30 pm
Short-term memory loss is a normal part of aging, but can also be brought about by medical conditions like depression or a brain injury, says Sanam Hafeez, PsyD, psychologist and founder of ...
- Talk Therapy May Improve Depression, Anxiety in People with Dementiaon October 16, 2022 at 4:59 pm
Confusion and loss of memory can exacerbate anxiety in people ... able to advise on finding a psychologist or counselor. Depression and anxiety are common co-occurring symptoms of various dementias.
- Why Am I So Forgetful? How to Improve Your Memory and Remember Almost Anythingon October 13, 2022 at 9:06 pm
Unhealthy lifestyle choices are another major factor in memory loss. Just as eating too many ... "When we are experiencing feelings of depression and prolonged anxiety or stress, we become ...
via Bing News